|Tuesday, March 23, 2021|
|12:00 PM - 01:00 PM ET|
Please join us for a presentation that will provide an introduction to legal matters implicated by cell and gene therapies, with an emphasis on IP, regulatory and transactional consideration. This program will enable lawyers to understand some of the more complex legal IP and regulatory issues encountered from time to time with cell and gene therapies and to have a sense of the market for legal risk allocation in contracting around cell and gene therapies.
To register, please contact Steven Perdziola.
CLE credit: CLE credit is currently pending approval in ONLY: CA, IL, *NY, PA, TX and VA and in CT, FL, & NJ via reciprocity. Those seeking CLE credit in any other state/jurisdiction may be provided with a General Certificate of Attendance.